Logo

Leland Hartwell, Paul Nurse, Timothy Hunt, Stephen Friend and Leroy Hood

Oct 12, 2001
Premium

Leland Hartwell, director of the Fred Hutchinson Cancer Research Center in Seattle, and co-founder of Rosetta Inpharmatics, was awarded the Nobel Prize in Physiology or Medicine for 2001, the Karolinksa Institute announced this week.

Hartwell, along with Paul Nurse and Timothy Hunt, both of London’s Imperial Cancer Research Fund, received the award for their discoveries of “key regulators of the cell cycle.”

Hartwell founded Rosetta Inpharmatics with Stephen Friend, now CEO, and Leroy Hood in 1996. The company, acquired in May by Merck, produces the Rosetta Resolver gene expression analysis software. Hartwell and Friend developed the Rosetta Resolver’s core gene expression pattern analysis method while working on a project at the Hutchinson Center.

Filed under

Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.